FibroGen Inc (FGEN) — Cash Flow-to-Debt Ratio
FibroGen Inc (FGEN) has a Cash Flow-to-Debt Ratio of -0.02x as of September 2025, meaning its operating cash flow of $-1.85 Million could theoretically repay 0% of its total liabilities ($119.53 Million) in one year. See FGEN financial flexibility score to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
FibroGen Inc Cash Flow-to-Debt Ratio (2012–2024)
Historical debt coverage capacity for FibroGen Inc across 13 annual periods. For the full cash flow conversion analysis, see FibroGen Inc (FGEN) cash conversion ratio.
Annual Cash Flow-to-Debt Ratio for FibroGen Inc (2012–2024)
Year-by-year debt coverage analysis for FibroGen Inc. Check cash flow quality index of FibroGen Inc to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.35x | $-138.00 Million | $398.16 Million | ▲ +35.6% |
| 2023 | -0.54x | $-315.02 Million | $585.73 Million | ▼ -125.4% |
| 2022 | -0.24x | $-145.93 Million | $611.57 Million | ▼ -58.1% |
| 2021 | -0.15x | $-82.23 Million | $544.71 Million | ▼ -171.3% |
| 2020 | 0.21x | $81.60 Million | $385.39 Million | ▲ +186.6% |
| 2019 | -0.24x | $-78.70 Million | $321.99 Million | ▼ -13.0% |
| 2018 | -0.22x | $-76.14 Million | $352.13 Million | ▼ -2.8% |
| 2017 | -0.21x | $-66.51 Million | $316.20 Million | ▼ -971.4% |
| 2016 | 0.02x | $7.11 Million | $294.44 Million | ▲ +135.6% |
| 2015 | -0.07x | $-18.57 Million | $273.75 Million | ▼ -173.5% |
| 2014 | 0.09x | $22.41 Million | $242.85 Million | ▼ -32.6% |
| 2013 | 0.14x | $25.92 Million | $189.35 Million | ▲ +450.2% |
| 2012 | -0.04x | $-5.61 Million | $143.40 Million | — |